Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-07-03FDA Approved: OLANZAPINE — Original Application (HEC Pharm USA Inc.)
FDA approved the original Abbreviated New Drug Application for olanzapine (generic) submitted by HEC Pharm USA Inc. The approval enables a g…
-
FDA approval · 2018-06-29FDA Approved: ARISTADA INITIO — Original Application (Alkermes, Inc.)
FDA approved ARISTADA INITIO (aripiprazole lauroxil) under an original application, establishing the initiating regimen for this long-acting…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study) [Phase 3]
ENLIGHTEN-1, a Phase 3 trial of ALKS 3831 in adults with acute exacerbation of schizophrenia, has completed and posted its results.
-
CLINICAL_TRIALS trial_result · 2018-06-21Clinical Trial Update: Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia [NA]
Clinical trial update reporting completed results on the metabolic effects of combining an atypical antipsychotic with valproate on glucose …
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia [Phase 4]
Phase 4 clinical trial update examining telmisartan as an adjunctive treatment for metabolic problems in schizophrenia or schizoaffective di…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients
A completed clinical trial examining direct measurements of cardiometabolic risk in patients with schizophrenia who are being treated.
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Feasibility and Acceptability of a Smartphone App to Assess Early Warning Signs of Psychosis Relapse
A completed clinical trial evaluating a smartphone app to monitor early warning signs of relapse in schizophrenia and related psychotic diso…
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Improving Representative Payeeship for People With Psychiatric Disabilities and Their Families [NA]
A clinical trial examining how to improve representative payeeship for people with psychiatric disabilities and their families has completed…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia [Phase 1]
A Phase 1 study evaluating the pharmacokinetics, safety, and tolerability of aripiprazole in adults with schizophrenia has completed.
-
CLINICAL_TRIALS research · 2018-06-11Clinical Trial Update: Effect of Dietary Fiber Supplement on the Intestinal Microbiota Among Schizophrenia Patients [NA]
This clinical trial update investigates whether a dietary fiber supplement can alter the intestinal microbiota in patients with schizophreni…
-
FDA approval · 2018-06-08FDA Approved: HALOPERIDOL — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for HALOPERIDOL LACTATE from Fresenius Kabi USA, LLC, authorizing changes to the marketed halope…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia [Phase 2]
This update reports results from a Phase 2 efficacy and safety study evaluating cognitive deficits in adults with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With Schizophrenia [Phase 2]
Phase 2 trial evaluating safety and efficacy for cognitive deficits in adults with schizophrenia, sponsored by AbbVie; the study has complet…
-
CLINICAL_TRIALS research · 2018-06-06Clinical Trial Update: Augmentation of Neuronal Network Plasticity in Schizophrenia [NA]
The update reports a trial on augmentation of neuronal network plasticity in schizophrenia, sponsored by Universitätsklinikum Hamburg-Eppend…
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: Exercise and Cognitive Training [NA]
A clinical trial evaluating exercise and cognitive training for schizophrenia, schizoaffective disorder, and bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-23Clinical Trial Update: Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System [Phase 2]
This document reports the completed Phase 2 exploratory trial evaluating the functionality of an integrated call center for a digital medici…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: Social Cognition Training in Schizophrenia [NA]
This Clinical Trial Update notes a completed study conducted at Oslo University Hospital evaluating social cognition training in schizophren…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Berberine Effect on Cytokine, CRP, Metabolic Disturbance as an Adjunctive Therapy in Schizophrenia Patients [NA]
This clinical trial update reports on berberine used as an adjunctive therapy to schizophrenia, assessing effects on cytokines, CRP, and met…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Using Motivational Techniques to Increase Levels of Physical Activity in Long Term Psychiatric Inpatient Wards
A completed clinical trial from Oslo University Hospital evaluated motivational techniques to increase physical activity levels among long-t…
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia [NA]
A completed double-blind, placebo-controlled trial evaluating adjunctive aripiprazole for symptomatic hyperprolactinemia in premenopausal wo…
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Optimization of Treatment and Management of Schizophrenia in Europe [Phase 4]
This Phase 4 clinical trial update investigates optimization of treatment and management of schizophrenia in Europe. The study is marked as …
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Systematic Evaluation of Antiviral Medication in Schizophrenia [Phase 2]
A Phase 2 clinical trial evaluating an antiviral medication as a treatment approach for schizophrenia and schizoaffective disorder has compl…
-
CLINICAL_TRIALS trial_result · 2018-05-08Clinical Trial Update: Salsalate as an Adjunctive Treatment for Patients With Schizophrenia [Phase 4]
Phase 4 study evaluating salsalate as an adjunctive treatment for schizophrenia and schizoaffective disorder; the trial completed and result…
-
CLINICAL_TRIALS trial_result · 2018-05-04Clinical Trial Update: Functional Neuroimaging Effects of Cognitive Remediation Training [Phase 3]
Phase 3 trial update examining the functional neuroimaging effects of cognitive remediation training in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680) [Phase 2]
An extension study evaluating long-term safety and efficacy of ABT-126 in subjects with schizophrenia; the Phase 2 trial was terminated.